Lack of clarity in reports of adverse events: is there any harm?
- PMID: 23159572
- DOI: 10.1016/j.pain.2012.10.019
Lack of clarity in reports of adverse events: is there any harm?
Comment on
-
Adverse event reporting in randomised controlled trials of neuropathic pain: considerations for future practice.Pain. 2013 Feb;154(2):213-220. doi: 10.1016/j.pain.2012.08.012. Epub 2012 Nov 3. Pain. 2013. PMID: 23127360
References
-
- Cornelius VR, Sauzet O, Williams JE, Ayis S, Farquhar-Smith P, Ross JR, Branford RA, Peacock JL. Adverse event reporting in randomised controlled trials of neuropathic pain: considerations for future practice. PAIN®. 2013;154:213-220.
-
- Loke YK, Derry S. Reporting of adverse drug reactions in randomised controlled trials – a systematic survey. BMC Clin Pharmacol. 2001;1:3.
-
- Schroll JB, Maund E, Gotzsche PC. Challenges in coding adverse events in clinical trials: a systematic review. PLoS One. 2012;7:e41174.
-
- Woodworth TG, Furst DE, Strand V, Kempeni J, Fenner H, Lau CS, et al. Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies. J Rheumatol. 2000;2001:1163-1169.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources